8-BRMOADENOSINE-3 5 -CYC 100MG
|
8-Bromoadenosine-3',5'-cyclic monophosphate, C10H11BrN5O6P, CAS Number-23583-48-4
|
3429-J64469MC
|
EA
|
|
8-BRMOADENOSINE-3 5 -CYCL 50MG
|
8-Bromoadenosine-3',5'-cyclic monophosphate, C10H11BrN5O6P, CAS Number-23583-48-4
|
3429-J64469MF
|
EA
|
|
CIS-3-(BENZLOXYMETHL)CYC 250MG
|
CIS-3-(BENZLOXYMETHL)CYC 250MG - H62579-MD, 250 mg
|
3429-H62579MD
|
EA
|
|
1-DIMETHLAMINOMETHL CYC 250MG
|
1-(Dimethylaminomethyl)cyclopentanecarboxaldehyde, 97%, C9H17NO, CAS Number-39943-37-8
|
3429-H50751MD
|
EA
|
|
8-Bromoadenosine-3',5'-cyclic monophosph
|
8-Bromoadenosine-3',5'-cyclic monophosphate 250mg
|
3136-J64469MD
|
EA
|
|
5-BRMO-8-METHOXYQUINOLIN 250MG
|
5-Bromo-8-methoxyquinoline, 96%, C10H8BrNO, CAS Number-10522-47-1, quinoline, 5-bromo-8-methoxy, 250mg, 238.08, H315-H319-H335, GHS H Statement H315-H319-H335 Causes skin irritation. Causes serious eye irritation. May cause respiratory irri
|
3429-H54386MD
|
EA
|
|
3-METHL-5-3-PYRROLIDINY 250MG
|
3-Methyl-5-(3-pyrrolidinyl)-1,2,4-oxadiazole hydrochloride, C7H12ClN3O, CAS Number-1121057-52-0, 3-methyl-5-pyrrolidin-3-yl-1,2,4-oxadiazole hydrochloride, 3-methyl-5-3-pyrrolidinyl-1,2,4-oxadiazole hcl, 3-methyl-5-3-pyrrolidinyl-1,2,4-oxad
|
3429-H51664MD
|
EA
|
|
3-CYANOPYRIDN-5-BORNIC A 250MG
|
3-Cyanopyridine-5-boronic acid pinacol ester, 96%, C12H15BN2O2, CAS Number-402718-29-0
|
3429-H54385MD
|
EA
|
|
3-BRMO-5-TRIFLROMETHOXY 250MG
|
3-Bromo-5-(trifluoromethoxy)phenylacetic acid, 96%, C9H6BrF3O3, CAS Number-1092461-35-2, 3-bromo-5-trifluoromethoxy phenylacetic acid, jrd, 2-3-bromo-5-trifluoromethoxy phenyl acetic acid, 3-bromo-5-trifluoromethoxy phenyl acetic acid, 3-br
|
3429-H32419MD
|
EA
|
|